Open Your Free Demat Account
Enjoy low brokerage on delivery trades
The Aequs IPO witnessed active participation across retail, NII, and employee categories today. The overall subscription reached 3.11 times, with retail investors leading significantly. Tracking the category-wise subscription trends helps investors understand demand distribution and bidding momentum during the issue window.
Retail and NII categories showed strong early traction, while QIB participation was comparatively limited today. Investors can continue monitoring day-wise bidding to assess how overall sentiment shapes up through the duration of the IPO.
Explore the offering here
As of December 3, 2025 at 4:14 PM, the Aequs IPO was subscribed 3.11 times, driven largely by robust retail participation at 11.09 times, followed by NII at 2.96 times. The employee quota also saw healthy interest, while QIB bidding remained at 0.49 times.
Below is the detailed category-wise bidding snapshot:
Investor Category | Subscription (times) | Shares Offered* | Shares bid for | Total Amount (Rs Cr.)* |
Anchor Investors | 1 | 3,33,80,262 | 3,33,80,262 | 413.915 |
QIB (Ex Anchor) | 0.49 | 2,22,41,733 | 1,09,47,120 | 135.744 |
Non-Institutional Buyers | 2.96 | 1,11,24,399 | 3,29,30,280 | 408.335 |
bNII (bids above ₹10L) | 2.42 | 74,16,266 | 1,79,28,360 | 222.312 |
sNII (bids below ₹10L) | 4.05 | 37,08,133 | 1,50,01,920 | 186.024 |
Retail Investors | 11.09 | 74,16,266 | 8,22,81,000 | 1,020.284 |
Employees | 6.18 | 1,76,991 | 10,94,640 | 13.574 |
Total ** | 3.11 | 4,09,59,389 | 12,72,53,040 | 1,577.938 |
Total Applications: 5,77,771
*Based on the upper price band.
Aequs Ltd has launched a public issue of 7.43 crore equity shares. The allocation structure includes separate quotas for QIBs, NIIs, retail investors, and employees. With QIBs receiving the largest portion, the IPO is structured to engage multiple investor segments.
Below is the issue breakdown for quick reference:
Total Issue Size: 7,43,39,651 shares
Retail Allocation: 74.16 lakh shares
QIB Allocation: 5.56 crore shares
NII Allocation: 1.11 crore shares
Employee Quota: 1.76 lakh shares
Listing: NSE & BSE
Anchor Book: Opened on Dec 2, 2025
Category | Shares Offered | Amount (Rs Cr) | Size (%) |
Anchor Investor | 3,33,80,262 | 413.92 | 44.90% |
QIB | 5,56,21,995 | 689.71 | 74.82% |
NII | 1,11,24,399 | 137.94 | 14.96% |
bNII (bids above ₹10L) | 74,16,266 | 91.96 | 9.98% |
sNII (bids below ₹10L) | 37,08,133 | 45.98 | 4.99% |
Retail | 74,16,266 | 91.96 | 9.98% |
Employee | 1,76,991 | 2.19 | 0.24% |
Total | 7,43,39,651 | 921.81 | 100% |
The funds raised through the Aequs IPO will be directed toward:
Repayment or prepayment of borrowings
Funding capital expenditure for machinery and equipment
Investment into wholly-owned subsidiaries
Supporting operational growth initiatives
General corporate purposes
A total of 3,33,80,262 shares were allotted to anchor investors at a price of ₹124 per share.
Particulars | Details |
Anchor investors bid opening date | Dec 02, 2025 |
Anchor investor price | ₹124.00 |
Anchor investors as % of QIBs | 60.01% |
No. of shares locked-in for 30 days | 1,66,90,131 |
No. of shares locked-in for 90 days | 1,66,90,131 |
Anchor investors bid opening date | Dec 02, 2025 |
Click here to check out recently closed IPO
The Aequs IPO saw notable interest today, with retail and employee categories showing the strongest response. NII participation also contributed significantly to the overall subscription. While QIB demand was modest, anchor participation supported the offering’s institutional positioning.
Investors tracking the issue can follow day-wise bidding updates to get a clearer understanding of demand distribution across segments. As the subscription window continues, further shifts in investor activity may provide deeper insight into overall sentiment.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Sudeep Pharma Ltd IPO.
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes. The securities are quoted as an example and not as a recommendation. Past performance is not necessarily a guide to future performance.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading